Accession Number: | 0001567619-21-017415 |
Date: | 2021-09-17 |
Issuer: | REVOLUTION MEDICINES, INC. (RVMD) |
Original Submission Date: |
WANG XIAOLIN
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
REDWOOD CITY, CA 94063
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-09-17 | S | 250 | d | $30.02 | 12,195 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("rsus") awards, the shares were sold upon the vesting of the rsus solely to cover applicable withholding taxes. |
f2 | includes 9,800 rsus. |